Sponsor Pipeline

Institut fuer Frauengesundheit Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 2
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05452213 Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy… Breast Cancer Recruiting
Phase 2
NCT05033756 Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in… Malignant Neoplasm of Breast Active, Not Recruiting
Not specified
NCT07531693 Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive… HR+/HER2- Early Breast Cancer Recruiting
NCT07708571 Evaluating the Effectiveness of Typology-based Coaching on Patients' Therapy Management HR+/HER2- Early Breast Cancer Recruiting
NCT07521202 IMPLEMENTING PATIENTS' COMPETENCE IN ORAL EBC THERAPY PERSISTENCE HR+/HER2- Early Breast Cancer Not Yet Recruiting
Disease Areas
Get alerts when Institut fuer Frauengesundheit's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free